151 related articles for article (PubMed ID: 4666626)
1. Response of the midpregnant human uterus to systemic administration of 15(S)-15-methyl-prostaglandin F2alpha.
Toppozada M; Béguin F; Bygdeman M; Wiqvist N
Prostaglandins; 1972 Oct; 2(4):239-49. PubMed ID: 4666626
[TBL] [Abstract][Full Text] [Related]
2. Midtrimester abortion induced by single intra-amniotic instillation of two dose schedules of 15(S)-15-methyl-prostaglandin F2alpha.
Lauersen NH; Wilson KH
Prostaglandins; 1975 Apr; 9(4):617-25. PubMed ID: 1153812
[TBL] [Abstract][Full Text] [Related]
3. High-dose intravenous administration of prostaglandin E 2 and F 2 for the termination of midtrimester pregnancies.
Hillier K; Embrey MP
J Obstet Gynaecol Br Commonw; 1972 Jan; 79(1):14-22. PubMed ID: 5021725
[TBL] [Abstract][Full Text] [Related]
4. Continuous extraovular administration of prostaglandin F2alpha for midtrimester abortion.
Lauersen NH; Wilson KH
Am J Obstet Gynecol; 1974 Sep; 120(2):273-80. PubMed ID: 4412615
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandins and abortion. III. Comparison of single intra-amniotic injections of 15-methyl prostaglandin F2alpha and prostaglandin F2alpha for termination of second-trimester pregnancy: an international multicenter study. World Health Organization Tast Force on the Use of Prostaglandins forthe Regulation of Fertility.
Am J Obstet Gynecol; 1977 Nov; 129(6):601-6. PubMed ID: 920761
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and acceptability of intravenously administered prostaglandin F as an abortifacient.
Csapo AI; Sauvage JP; Wiest WG
Am J Obstet Gynecol; 1971 Dec; 111(8):1059-63. PubMed ID: 5129560
[TBL] [Abstract][Full Text] [Related]
7. Mid-trimester abortion by vaginal administration of 9-deoxo-16, 16-dimethyl-9-methylene-PGE2.
Bygdeman M; Christensen N; Gréen K; Lundström V
Contraception; 1980 Aug; 22(2):153-64. PubMed ID: 7449380
[TBL] [Abstract][Full Text] [Related]
8. Effect of prostaglandin E1 on the midpregnant human uterus. Intravenous, intramuscular, intra-amniotic, and vaginal administration.
Wiqvist N; Bygdeman M; Kwon SU; Mukherjee T; Roth-Brandel U
Am J Obstet Gynecol; 1968 Oct; 102(3):327-32. PubMed ID: 5675883
[TBL] [Abstract][Full Text] [Related]
9. Cervical dilatation with prostaglandin analogues prior to vaginal termination of first trimester pregnancy in nulliparous patients.
Karim SM; Choo HT; Cheng P
Prostaglandins; 1975 Apr; 9(4):631-8. PubMed ID: 1153813
[TBL] [Abstract][Full Text] [Related]
10. Interruption of pregnancy by prostaglandin 15-methyl F2alpha.
Bolognese RJ; Corson SL
Fertil Steril; 1975 Jul; 26(7):695-9. PubMed ID: 1149900
[TBL] [Abstract][Full Text] [Related]
11. Effect of intravenous infusion of prostaglandin E1 and E2 on motility of the pregnant human uterus. Prostaglandins and related factors 65.
Bygdeman M; Kwon SU; Mukherjee T; Wiqvist N
Am J Obstet Gynecol; 1968 Oct; 102(3):317-26. PubMed ID: 5675882
[TBL] [Abstract][Full Text] [Related]
12. The effect of a 10 cm2, 0.5% 15-ME-PGF2alpha methyl ester intravaginal silastic device on abortion and plasma prostaglandin concentration.
Lauersen NH; Wilson KH
Prostaglandins; 1977 Apr; 13(4):755-62. PubMed ID: 857275
[TBL] [Abstract][Full Text] [Related]
13. The induction of abortion by prostaglandin F 2 .
Kinoshita K; Wagatsuma T; Hogaki M; Sakamoto S
Am J Obstet Gynecol; 1971 Nov; 111(6):855-7. PubMed ID: 5166392
[TBL] [Abstract][Full Text] [Related]
14. Mid-trimester abortion with 15 (S) methyl prostaglandin F 2 alpha.
Leibman T; Saldana L; Schulman H; Cunningham MA; Randolph G
Prostaglandins; 1974 Sep; 7(5):443-8. PubMed ID: 4424912
[TBL] [Abstract][Full Text] [Related]
15. Effects of oral administration of prostaglandins E 2 and F 2- on the human uterus.
Karim SM
J Obstet Gynaecol Br Commonw; 1971 Apr; 78(4):289-93. PubMed ID: 5558311
[No Abstract] [Full Text] [Related]
16. Induction of therapeutic abortion using either extra-amniotic prostaglandin F-2-alpha or hypertonic saline followed by oxytocin.
Lange AP; Secher NJ; Pedersen GT
Prostaglandins; 1974 Apr; 6(2):149-57. PubMed ID: 4847514
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and acceptability of 15(S)-15-methyl-prostaglandin E2-methyl ester for midtrimester pregnancy termination.
Bieniarz J; Hunter G; Scommegna A
Am J Obstet Gynecol; 1974 Nov; 120(6):840-3. PubMed ID: 4429095
[TBL] [Abstract][Full Text] [Related]
18. Intrauterine injection of 15(S)-15-methyl-prostaglandin F2alpha for termination of early pregnancy in out-patient.
Ylikorkala O; Kirkinen P; Jouppila P; Järvinen PA
Prostaglandins; 1975 Aug; 10(2):333-41. PubMed ID: 1178911
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin-oxytocin enhancement.
Seppälä M; Vara P
Br Med J; 1972 Mar; 1(5802):747. PubMed ID: 5015335
[TBL] [Abstract][Full Text] [Related]
20. Induction of abortion by extra-ammiotic prostaglandin administration.
Wiqvist N; Béguin F; Bygdeman M; Fernström I; Toppozada M
Prostaglandins; 1972 Jan; 1(1):37-53. PubMed ID: 4660224
[No Abstract] [Full Text] [Related]
[Next] [New Search]
